FDA Approves Ensitrelvir to Prevent COVID-19 After Exposure - Quiz - MDSpire

FDA Approves Ensitrelvir to Prevent COVID-19 After Exposure

Phase 3 data showed a 67% reduction in symptomatic infection among exposed household contacts who tested negative at baseline.

  • By

  • Kathryn Wighton

  • June 2, 2026

  • 3 min

Share

Original Source(s)

FDA Approves Ensitrelvir to Prevent COVID-19 After Exposure

  • by Kathryn Wighton

  • June 2, 2026

Related Content

Measles-Related Vitamin A Searches Rise

Google Trends data showed increased US search interest in vitamin A and cod liver oil during the 2025 measles outbreak, but normalized search data cannot determine actual product use, dosing behavior, or harms.

RFK Jr. Takes Health Agenda on the Road

Touring Ohio, RFK Jr. highlights food quality and recovery services while steering attention away from vaccine controversies.

Top 10 CDC Updates Physicians Should Know

Recent CDC advisories, testing updates, and immunization recommendations highlight developments in infectious diseases, immunization, and diagnostic testing relevant to physicians across multiple specialties.